Role of free fatty acids in regulating gastric emptying and gallbladder contraction

Digestion

Volumn 74, Issue 3-4, 2007, Pages 131-139

  Degen, Lukas ^a   Matzinger, Daniel ^a   Drewe, Juergen ^a   Nisslé, Sonja ^a   Maecke, Helmut ^a   Lengsfeld, Hans ^b   Hadvary, Paul ^b   Beglinger, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Cholecystokinin; Free fatty acids; Gallbladder contraction; Gastric emptying; Orlistat; Tetrahydrolipstatin

Indexed keywords

CHOLECYSTOKININ; FATTY ACID; PLACEBO; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOGRAPHY; GALLBLADDER CONTRACTION; HORMONE RELEASE; HUMAN; LIPID DIET; MALE; NORMAL HUMAN; PERFUSION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SCINTIGRAPHY; STOMACH EMPTYING;

ADULT; CHOLECYSTOKININ; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; GALLBLADDER EMPTYING; GASTRIC EMPTYING; HUMANS; LACTONES; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 34247249318     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098560     Document Type: Article

References (35)

1. Mayer EA: The physiology of gastric storage and emptying; in Johnson LR (ed): Physiology of the Gastrointestinal Tract. New York, Raven Press, 1994, pp 929-976.
2. Solomon TE: Control of exocrine pancreatic secretion; in Johnson LR (ed): Physiology of the Gastrointestinal Tract. New York, Raven Press, 1994, pp 1499-1530.
3. Meyer JH, Mayer EA, Jehn D, Gu Y, Fink AS, Fried M: Gastric processing and emptying of fat. Gastroenterology 1986;90(5 Pt 1):1176-1187.
4. Hildebrand P, Beglinger C, Gyr K, Jansen JB, Rovati LC, Zuercher M, et al: Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 1990;85:640-646.
5. Beglinger C, Hildebrand P, Adler G, Werth B, Luo H, Delco F, et al: Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man. Eur J Clin Invest 1992;22:827-834.
6. Matzinger D, Gutzwiller JP, Drewe J, Orban A, Engel R, D'Amato M, et al: Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. Am J Physiol 1999;277:R1718-R1724.
7. Matzinger D, Degen L, Drewe J, Meuli J, Duebendorfer R, Ruckstuhl N, et al: The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 2000;46:688-693.
8. Tso P: Intestinal lipid absorption; in Johnson LR (ed): Physiology of the Gastrointestinal Tract. New York, Raven Press, 1994, pp 1867-1908.
9. 2+-dependent mechanism in the enteroendocrine cell line STC-1. J Physiol (Lond) 1998;513:11-18.
10. Guimbaud R, Moreau JA, Bouisson M, Durand S, Escourrou J, Vaysse N, et al: Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas 1997;14:76-82.
11. Hildebrand P, Petrig C, Burckhardt B, Ketterer S, Lengsfeld H, Fleury A, et al: Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release. Gastroenterology 1998;114:123-129.
12. Maas MI, Hopman WP, Gelder BV, Jacobs M, De Haan AF, Katan MB, et al: Does intraduodenal administration of sucrose polyester (Olestra) cause satiation in humans? Appetite 1999;33:195-208.
13. Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JB, Zach D, et al: Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989;2:12-15.
14. Schwizer W, Asal K, Kreiss C, Mettraux C, Borovicka J, Remy B, et al: Role of lipase in the regulation of upper gastrointestinal function in humans. Am J Physiol 1997;273:G612-G620.
15. Fried M, Erlacher U, Schwizer W, Lochner C, Koerfer J, Beglinger C, et al: Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991;101:503-511.
16. Liddle RA, Morita ET, Conrad CK, Williams JA: Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 1986;77:992-996.
17. Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, et al: Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. J Clin Invest 1989;84:1220-1225.
18. Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM, Chapman NJ, et al: Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol 1989;257:G284-G90.
19. Stivland T, Camilleri M, Vassallo M, Proano M, Rath D, Brown M, et al: Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991;101:107-115.
20. Cunningham KM, Baker RJ, Horowitz M, Maddox AF, Edelbroek MA, Chatterton BE: Use of technetium-99m(V)thiocyanate to measure gastric emptying of fat. J Nucl Med 1991;1991:878-881.
21. Degen LP, von Flue MO, Collet A, Hamel C, Beglinger C, Harder F: Ileocecal segment transposition does not alter whole gut transit in humans. Ann Surg 1997;226:746-752.
22. Sachs L: Angewandte Statistik. Berlin, Springer, 1984.
23. McLaughlin J, Grazia Lucà M, Jones MN, D'Amato M, Dockray GJ, Thompson DG: Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 1999;116:46-53.
24. Meyer JH, Elashoff JD, Domeck M, Levy A, Jehn D, Hlinka M, et al: Control of canine gastric emptying of fat by lipolytic products. Am J Physiol 1994;266:G1017-G1035.
25. Ackroff K, Sclafani A: Effects of the lipase inhibitor orlistat on intake and preference for dietary fat in rats. Am J Physiol 1996;271:R48-R54.
26. James WP, Avenell A, Broom J, Whitehead J: A one-year trial to assess the value of orlistat in the management of obesity. Int J Obes Relat Metab Disord 1997;21(suppl 3):S24-S30.
27. Lekkerkerker JF, Diemont WL, Koopmans PP: Orlistat and weight loss (letter). Lancet 1998;352:1473-1474.
28. Hildebrand P, Petrig C, Burckhardt B, Ketterer S, Lengsfeld H, Fleury A, et al: Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release. Gastroenterology 1998;114:123-129.
29. Carriere F, Barrowman JA, Verger R, Laugier R: Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 1993;105:876-888.
30. Carriere F, Renou C, Lopez V, De Caro J, Ferrato F, Lengsfeld H, et al: The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals. Gastroenterology 2000;119:949-960.
31. Carriere F, Renou C, Ransac S, Lopez V, De Caro J, Ferrato F, et al: Inhibition of gastrointestinal lipolysis by orlistat during digestion of test meals in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2001;281:G16-G28.
32. Meyer JH, Gu YG, Jehn D, Doty JE: Factors that affect the performance of lipase on fat digestion and absorption in a canine model of pancreatic insufficiency. Pancreas 1994;9:13-623.
33. Feinle-Bisset C, Patterson M, Ghatei MA, Bloom SR, Horowitz M: Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. Am J Physiol Endocrinol Metab 2005;289:E948-E953.
34. Froehlich F, Hartmann D, Guezelhan C, Gonvers JJ, Jansen JB, Fried M: Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study. Dig Dis Sci 1996;41:2404-2408.
35. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA: Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985;75:1144-1152.